GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » Capex-to-Operating-Income

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Capex-to-Operating-Income : 0.00 (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capital Expenditure for the three months ended in . 20 was ₫0.00 Mil. Its Operating Income for the three months ended in . 20 was ₫0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Capex-to-Operating-Income Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Capex-to-Operating-Income Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Capex-to-Operating-Income

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Capex-to-Operating-Income

Competitive Comparison of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income falls into.



Pharmedic Pharmaceutical Medicinal Joint Stock Company Capex-to-Operating-Income Calculation

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income for the fiscal year that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income for the quarter that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009